Redirect Notice
 The previous page is sending you to https://pharmashots.com/1251/leo-pharma-enters-into-a-sub-licensing-agreement-with-bausch-health-to-develop-and-commercialize-brodalumab-for-moderate-to-severe-psoriasis-outside-europe.

 If you do not want to visit that page, you can return to the previous page.